Robert Oostendorp
Overview
Explore the profile of Robert Oostendorp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fibbe W, Bernardi R, Charbord P, Krause D, Lo Celso C, Mendez-Ferrer S, et al.
Hemasphere
. 2022 May;
6(5):e0714.
PMID: 35509429
No abstract available.
2.
Jaffredo T, Balduini A, Bigas A, Bernardi R, Bonnet D, Canque B, et al.
Hemasphere
. 2021 Dec;
5(12):e669.
PMID: 34853826
No abstract available.
3.
Muller T, Pennisi S, Zwick A, Decker S, Klein C, Rister B, et al.
Leukemia
. 2019 Mar;
33(5):1296-1301.
PMID: 30816332
No abstract available.
4.
Habringer S, Lapa C, Herhaus P, Schottelius M, Istvanffy R, Steiger K, et al.
Theranostics
. 2018 Jan;
8(2):369-383.
PMID: 29290814
C-X-C chemokine receptor 4 (CXCR4) is a transmembrane receptor with pivotal roles in cell homing and hematopoiesis. CXCR4 is also involved in survival, proliferation and dissemination of cancer, including acute...
5.
Steinhoff G, Nesteruk J, Wolfien M, Kundt G, Borgermann J, David R, et al.
EBioMedicine
. 2017 Aug;
22:208-224.
PMID: 28781130
Objective: The phase III clinical trial PERFECT was designed to assess clinical safety and efficacy of intramyocardial CD133 bone marrow stem cell treatment combined with CABG for induction of cardiac...
6.
Vasold J, Wagner M, Drolle H, Deniffel C, Kutt A, Oostendorp R, et al.
Leuk Res
. 2014 Dec;
39(2):257-62.
PMID: 25542695
Immune therapy for acute myeloid leukaemia (AML) has been largely disappointing. One possible explanation might lie in the microenvironment of the bone marrow, comprising cellular (e.g. mesenchymal stromal cells, MSC)...
7.
Lutzny G, Kocher T, Schmidt-Supprian M, Rudelius M, Klein-Hitpass L, Finch A, et al.
Cancer Cell
. 2013 Jan;
23(1):77-92.
PMID: 23328482
Tumor cell survival critically depends on heterotypic communication with benign cells in the microenvironment. Here, we describe a survival signaling pathway activated in stromal cells by contact to B cells...
8.
Hoellein A, Graf S, Bassermann F, Schoeffmann S, Platz U, Holzlwimmer G, et al.
Mol Cell Biol
. 2012 Apr;
32(13):2416-27.
PMID: 22508990
Cks1 is an activator of the SCF(Skp2) ubiquitin ligase complex that targets the cell cycle inhibitor p27(Kip1) for degradation. The loss of Cks1 results in p27(Kip1) accumulation and decreased proliferation...
9.
McCullar V, Oostendorp R, Panoskaltsis-Mortari A, Yun G, Lutz C, Wagner J, et al.
Exp Hematol
. 2008 Feb;
36(5):598-608.
PMID: 18295962
Objective: Human natural killer (NK) cell maturation involves the orderly acquisition of NK cell receptors. Our aim was to understand how stromal interactions and cytokines are important in this developmental...
10.
Krassowska A, Gordon-Keylock S, Samuel K, Gilchrist D, Dzierzak E, Oostendorp R, et al.
Exp Cell Res
. 2006 Sep;
312(18):3595-603.
PMID: 16952354
We investigated whether the in vitro differentiation of ES cells into haematopoietic progenitors could be enhanced by exposure to the aorta-gonadal-mesonephros (AGM) microenvironment that is involved in the generation of...